0016-3813
0016-3813
S0016-38132023000600501
10.24875/gmm.23000393
México
México
México
Estados Unidos
México
00
12
2023
00
12
2023
159
6
501
508
[
2021
398
10302
10302
786-802
]
[
2017
389
10075
10075
1238-52
]
[
2016
165
7
7
473-81
]
[
2013
62
2
2
245-52
]
[
2017
69
3 Suppl 1
3 Suppl 1
A7-8
]
[
2016
12
27-36
]
[
2014
63
3
3
506-20
]
[
2021
77
6
6
969-83
]
[
2016
11
9
9
1566-73
]
[
2018
34
4
4
536-50
]
[
GBD Chronic Kidney Disease Collaboration
2020
395
10225
10225
709-33
]
[
IHME [Internet]
]
[
2022
18
8
8
485-98
]
[
2020
396
10258
10258
1135-59
]
[
GHDx [Internet]:Seattle, Washington, Estados Unidos:GBD 2021 Global Burden of Disease Collaborative Network
]
[
INEGI [Internet]
]
[
INEGI. [Internet]
]
[
2010
8
9
]
[
GBD 2019 Diseases and Injuries Collaborators
2020
396
10258
10258
1204-22
]
[
GBD 2017 DALYs and HALE Collaborators
2018
392
10159
10159
1859-922
]
[
2016
388
10062
10062
e19-23
]
[
CONEVAL [Internet]
]
[
2021
32
11
11
2851-62
]
[
2022
18
11
11
724-37
]
[
2016
31
12
12
2086-94
]
[
2014
85
1
1
158-65
]
[
2007
18
6
6
1922-7
]
[
2006
354
23
23
2473-83
]
[
1987
11
5 Suppl
5 Suppl
73S-8S
]
[
37
3
3
478-94
]
[
2017
69
2
2
321-3
]
[
2016
67
2
2
342-4
]
[
2008
110
3
3
c158-63
]
[
CKD-EPI Investigators
2012
367
1
1
20-9
]
[
2021
32
1
1
127-37
]
[
Look AHEAD Research Group
2014
2
10
10
801-9
]
[
Kidney Disease:Improving Global Outcomes (KDIGO) Diabetes Work Group
2022
102
5S
5S
S1-127
]
[
2001
135
2
2
73-87
]
[
The EMPA-KIDNEY Collaborative Group
2023
388
2
2
117-27
]
[
2021
2
6
6
1042-7
]
[
2021
36
6
6
1030-8
]
[
2019
39
3
3
300-7
]
[
2021
14
11
11
2285-94
]
[
2021
14
4
4
1197-206
]
[
2019
380
2
2
142-51
]
[
2023
388
11
11
969-79
]
[
2019
178
3
3
521-535.e23
]
[
2023
65 Supl 1
s163-8
]
[
2016
375
20
20
1961-71
]